Polyphenols nudge insulin and hormones in PCOS, but not testosterone

Polycystic ovary syndrome is an endocrine condition with high prevalence among women of reproductive age, and improving insulin sensitivity and hormone regulation is a central goal of its management. Different treatments have been tested toward that end, and polyphenols have recently emerged as a promising option for these women. Until now there were no comprehensive systematic recommendations on polyphenols for PCOS. This review pooled the randomised evidence to ask whether they genuinely move the markers that matter in the condition.

The authors searched PubMed, the Cochrane Library and Embase for randomised controlled trials comparing polyphenols with placebo in women with PCOS. Fifteen trials comprising 916 patients were included, of whom 445, around 49%, received polyphenols. Results were combined using a random-effects model to calculate mean differences and standardised mean differences between groups. The outcomes examined included serum insulin, BMI, luteinising hormone and testosterone levels.

Compared with placebo, polyphenols significantly reduced serum insulin, with a mean difference of 2.49 lower, reduced BMI by a mean of 0.12, and lowered luteinising hormone. Testosterone showed no significant difference between groups. The BMI change, while statistically significant, is small in absolute terms. The authors conclude the findings support the effectiveness of polyphenols on insulin, luteinising hormone and BMI in women with PCOS, while the androgen picture was left unchanged.

Insulin resistance and elevated luteinising hormone are central features of PCOS, so interventions that shift both deserve attention. This pooled analysis strengthens the case that polyphenols act on the metabolic and hormonal side of the condition, while the null result on testosterone suggests they do not directly address the androgen excess behind many PCOS symptoms. Open questions include which specific polyphenols work best, for how long, and whether these modest marker changes translate into outcomes women actually feel.

For women with PCOS curious about polyphenol supplements, this evidence suggests genuine but modest effects on insulin and luteinising hormone, and a very small effect on BMI. It is not evidence that polyphenols change testosterone, and nothing here positions them as a replacement for established management. Since polyphenols are a broad category rather than a single compound, the finding is best read as a promising signal for the class rather than an endorsement of any one product.